Thus, tumor PD-L1 expression was upregulated following X-ray radiation therapy and neutron radiation therapy compared to that in non-irradiated tumors, suggesting that anti-PD-L1 immune therapy may be effective in combination with X-ray or neutron irradiation for the treatment of NSCLC. The gene discussed is CD274; the disease is neoplasm.